X0306 5 2020-12-31 0 0 1 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001632384 Galante Joseph C 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2021-11-20 4 P 0 75 3.02 A 29467 D Common Stock 2020-11-23 4 P 0 75 3.03 A 29542 D Common Stock 2020-11-24 4 P 0 75 3.03 A 29617 D Common Stock 2020-11-25 4 P 0 75 3.01 A 29692 D Common Stock 2020-11-27 4 P 0 75 3.01 A 29767 D Common Stock 2020-11-30 4 P 0 75 3.05 A 29842 D Common Stock 2020-12-01 4 P 0 75 3.01 A 29917 D Common Stock 2020-12-02 4 P 0 75 3.03 A 29992 D Common Stock 2020-12-03 4 P 0 75 3.02 A 30067 D Common Stock 2020-12-04 4 P 0 75 3.02 A 30142 D Common Stock 2020-12-07 4 P 0 75 3.01 A 30217 D Common Stock 2020-12-08 4 P 0 75 3.05 A 30292 D Common Stock 2020-12-09 4 P 0 75 3.03 A 30367 D Common Stock 2020-12-10 4 P 0 75 3.05 A 30442 D Common Stock 2020-12-11 4 P 0 75 3.04 A 30517 D Common Stock 2020-12-14 4 P 0 75 3.04 A 30592 D Common Stock 2020-12-15 4 P 0 75 3.03 A 30667 D Common Stock 2020-12-16 4 P 0 75 3.03 A 30742 D Common Stock 2020-12-17 4 P 0 75 3.13 A 30817 D Common Stock 2020-12-18 4 P 0 75 3.17 A 30892 D Common Stock 2020-12-21 4 P 0 75 3.15 A 30967 D Common Stock 2020-12-22 4 P 0 75 3.13 A 31042 D Common Stock 2020-12-23 4 P 0 75 3.13 A 31117 D Common Stock 2020-12-24 4 P 0 75 3.11 A 31192 D Common Stock 2020-12-28 4 P 0 75 3.11 A 31267 D Common Stock 2020-12-29 4 P 0 75 3.05 A 31342 D Common Stock 2020-12-30 4 P 0 75 3.08 A 31417 D The purchases reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Filing 3 of 3 Joseph C. Galante by /s/ Michael Bonner as attorney-in-fact 2021-02-05